Skip to main content
ORTHOCELL LIMITED logo

ORTHOCELL LIMITED — Investor Relations & Filings

Ticker · OCC ISIN · AU000000OCC6 ASX Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2022-05-11 Share Issue/Capital Cha…
Country AU Australia
Listing ASX OCC

About ORTHOCELL LIMITED

https://orthocell.com/

Orthocell Limited is a regenerative medicine company focused on the development and commercialization of innovative technologies for the repair and regeneration of human soft tissue. The company’s core product portfolio includes the CelGro platform, a naturally derived collagen medical device designed to facilitate tissue repair and reconstruction in applications such as dental bone and soft tissue regeneration, nerve repair, and tendon repair. Orthocell also specializes in advanced cellular therapies, notably Ortho-ATI (Autologous Tenocyte Implantation) for treating chronic tendon injuries and Ortho-ACI (Autologous Chondrocyte Implantation) for cartilage repair. These therapies utilize a patient's own cells to restore function and structure to damaged tissues. The company aims to provide restorative solutions that improve clinical outcomes and offer alternatives to traditional surgical interventions.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - OCC 7 pages 30.3KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Notification of Issue, Conversion or Payment up of Unquoted Equity Securities' and details the issuance of unquoted securities under an employee incentive scheme. It includes specifics such as the number of securities issued, issue date, security descriptions, and compliance with ASX listing rules. There is no financial performance data, management discussion, or report content. The document is an announcement regarding the issuance of securities, fitting the category of Share Issue/Capital Change rather than a full financial report or other categories.
2022-05-11 English
Appendix 4C - Quarterly 8 pages 691.5KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Report – March 2022' and is dated 29 April 2022. It provides detailed information on the company's activities, regulatory approvals, clinical trials, market entry strategies, sales milestones, manufacturing capacity upgrades, and financial data such as cash outflows and cash balance for the quarter ended 31 March 2022. The content includes substantive financial and operational data for a period shorter than a full fiscal year, consistent with a quarterly report. There is no indication that this is merely an announcement or a summary; the document contains detailed narrative and data typical of an Interim / Quarterly Report. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2022
2022-04-28 English
Notification regarding unquoted securities - OCC 7 pages 30.1KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Notification of Issue, Conversion or Payment up of Unquoted Equity Securities' and details the issuance of unquoted options under an employee incentive scheme by Orthocell Limited. It includes specifics such as the number of securities issued, issue dates, and references to ASX listing rules. The content focuses on the announcement of new securities issued, not on financial results, management changes, or other report types. The document length is 6866 characters, which is sufficient to contain substantive information about the securities issuance. Therefore, this document fits the category of a Share Issue/Capital Change announcement.
2022-04-20 English
Regulatory Approval for Remplir Nerve Repair Device 3 pages 303.5KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Orthocell Limited has received Australian regulatory approval (TGA) for its Remplir™ nerve repair device. It discusses the product, market potential, clinical study results, and future plans for reimbursement and international approvals. There are no financial statements, earnings data, or detailed financial analysis. The document is an announcement of a regulatory approval event and product launch, not a financial report, management discussion, or investor presentation. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is also not a regulatory filing in the sense of compliance documents or certifications. The content is best classified as a Regulatory Filings (RNS) type, which is the fallback for miscellaneous regulatory announcements and company news that do not fit other categories. The document length (8687 characters) and content confirm it is a detailed announcement rather than a brief notice or a full report.
2022-03-20 English
Pause in Trading 1 page 110.6KB
Regulatory Filings Classification · 100% confidence The document is a brief market release announcing a temporary pause in trading of the company's securities. It is very short (337 characters) and does not contain any financial data, report content, or detailed information. It is an official regulatory announcement related to trading status, not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-03-16 English
Trading Halt 2 pages 367.8KB
Regulatory Filings Classification · 100% confidence The document is a market announcement from Orthocell Limited regarding a trading halt requested under ASX Listing Rule 17.1. It states the halt is pending an upcoming announcement about regulatory approval of a medical device. The text is short (1944 characters) and does not contain any financial data, report content, or detailed disclosures. It is clearly an announcement about a trading halt, not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-03-16 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.